Tenders/Direct award decision, Pulsiocare hemodynamic monitor and device-specific consumables from 2026, Getinge Finland Oy
Open🇫🇮FinlandSupplies

Direct award decision, Pulsiocare hemodynamic monitor and device-specific consumables from 2026, Getinge Finland Oy

Auto-translated from fi
Original title: Suorahankintapäätös, Pulsiocare hemodynaamisella monitorilla ja laitekohtaiset käyttötarvikkeet 2026 alkaen, Getinge Finland Oy
Etelä-Savon hyvinvointialue
Published: Nov 14, 2026
Updated: Nov 18, 2026
Source: Hilma Finland

About This Opportunity

This is a supplies contract in the general supplies and health and medical services sectors, with a focus on Pharmaceuticals. Located in Finland, Europe, this opportunity is open to firms and consortiums.

Published through Hilma Finland, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the general supplies sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This is an advance notice — the formal tender is expected to be published shortly. Interested parties can use this time to prepare documentation and identify potential partners.

Description

Auto-translated from fi
Direct award decision, Pulsiocare hemodynamic monitor and device-specific consumables from 2026, Getinge Finland Oy Etelä-Savo Wellbeing Services County has requested a quote for a Pulsiocare hemodynamic monitor, including consumables, for the intensive care and monitoring unit of Mikkeli Central Hospital, starting from 2026. The procurement includes the device, consumables such as PiCCO catheters and ProAQT sensors, as well as device calibration for an indefinite contract period. The Mikkeli Central Hospital Intensive Care Unit treats critically ill adult patients with severe circulatory disorders, such as septic shock, cardiogenic shock, multiple organ failure, severe respiratory failure (ARDS), post-operative conditions after major surgeries, and polytrauma patients. The treatment of these patients requires continuous and precise hemodynamic assessment to support fluid management, vasoactive medication, and prevention of organ damage. The PiCCO system is particularly used in situations where conventional monitoring or uncalibrated cardiac output monitors do not provide sufficient information for treatment decisions. The unit currently uses ultrasound diagnostics and Swan Ganz catheters in the treatment of patients with severe circulatory failure. Echocardiography primarily provides a snapshot assessment rather than continuous information on the circulatory response to interventions. The European Society of Intensive Care Medicine (ESICM) emphasizes the primacy of echocardiography in the assessment of shock but also states that continuous monitoring of cardiac output and stroke volume should be used if the initial treatment does not yield a sufficient response or if monitoring of the treatment response requires it. Conventional monitoring values, such as blood pressure, heart rate, and urine output, do not provide sufficient information to support treatment decisions in these situations. The alternative monitoring methods in use also do not allow for simultaneous measurement of all critical hemodynamic variables, or their reliability decreases in severely ill patients. The PiCCO monitoring system to be procured enables the measurement of cardiac output and key variables for circulation and fluid balance from the same system. The system allows for simultaneous assessment of the patient's circulatory filling status and the amount of fluid accumulated in the lungs, which is crucial for targeting fluid therapy and monitoring the treatment response. In practice, the need for procurement is based on recurring patient situations where it is critical for treatment decisions to assess whether the patient still benefits from fluid therapy or if additional fluid increases the risk of respiratory failure and pulmonary edema. This information can help avoid complications from both under- and over-hydration and support patient-safe, evidence-based intensive care. The PiCCO system, based on thermodilution, is currently the only identified monitoring method that enables the production of this data from a single measurement, in addition to continuous cardiac output monitoring. A quote has been requested via email, and negotiations have been held with Getinge Finland Oy. The estimated total value of the procurement, EUR 83,192 (excl. VAT), exceeds the national threshold. The estimated total value is calculated for a 48-month period for an indefinite contract. The procurement is in accordance with the Common Procurement Vocabulary (CPV) of the European Union, CPV code 33100000-1. The contracting entity may choose direct award on the following grounds: Act on Public Procurement and Concession Contracts (1397/2016) Section 40 Direct Award 2) for technical reasons or reasons relating to the protection of exclusive rights, only a specific supplier can carry out the procurement; an additional condition is that there are no reasonable alternative or substitute solutions and that the lack of competition is not due to an artificial restriction of the procurement conditions. The contracting entity may choose direct award on the aforementioned grounds because the assessment of the clinical need of the intensive care unit has examined the available hemodynamic monitoring methods and their measurement methods in relation to the clinical need described above. The assessment found that the uncalibrated pulse wave-based systems in use and available on the market do not provide measurement data for extravascular lung water (EVLWI) and global end-diastolic volume (GEDI), which are essential for the unit's operations in optimizing fluid therapy and circulation for critically ill intensive care patients. According to the unit's assessment, the PiCCO system is the only identified solution that simultaneously meets the requirements for continuous hemodynamic monitoring and measurement of lung water and preload based on transpulmonary thermodilution. For this reason, no alternative solution meeting the technical and functional requirements has been identified. The device procurement, Pulsiocare hemodynamic monitor, costing EUR 15,800 (excl. VAT), will be funded from the investment appropriations for 2026 (investment number 1120). The total value of the procurement, EUR 83,192 (excl. VAT), exceeds the national threshold and consists of the device's purchase price, device-specific consumables procured under an indefinite contract, and post-warranty calibration. Eloisa commits to ordering 7 boxes of PiCCO catheters and 4 boxes of ProAQT sensors annually. The total value of the procurement is calculated for a 48-month period for an indefinite contract. Lot 1: Direct award decision, Pulsiocare hemodynamic monitor and device-specific consumables from 2026, Getinge Finland Oy Etelä-Savo Wellbeing Services County has requested a quote for a Pulsiocare hemodynamic monitor, including consumables, for the intensive care and monitoring unit of Mikkeli Central Hospital, starting from 2026. The procurement includes the device, consumables such as PiCCO catheters and ProAQT sensors, as well as device calibration for an indefinite contract period. The unit currently uses ultrasound diagnostics and Swan Ganz catheters in the treatment of patients with severe circulatory failure. Echocardiography primarily provides a snapshot assessment rather than continuous information on the circulatory response to interventions. The European Society of Intensive Care Medicine (ESICM) emphasizes the primacy of echocardiography in the assessment of shock but also states that continuous monitoring of cardiac output and stroke volume should be used if the initial treatment does not yield a sufficient response or if monitoring of the treatment response requires it. Conventional monitoring values, such as blood pressure, heart rate, and urine output, do not provide sufficient information to support treatment decisions in these situations. The alternative monitoring methods in use also do not allow for simultaneous measurement of all critical hemodynamic variables, or their reliability decreases in severely ill patients. The PiCCO monitoring system to be procured enables the measurement of cardiac output and key variables for circulation and fluid balance from the same system. The system allows for simultaneous assessment of the patient's circulatory filling status and the amount of fluid accumulated in the lungs, which is crucial for targeting fluid therapy and monitoring the treatment response. In practice, the need for procurement is based on recurring patient situations where it is critical for treatment decisions to assess whether the patient still benefits from fluid therapy or if additional fluid increases the risk of respiratory failure and pulmonary edema. This information can help avoid complications from both under- and over-hydration and support patient-safe, evidence-based intensive care. The PiCCO system, based on thermodilution, is currently the only identified monitoring method that enables the production of this data from a single measurement, in addition to continuous cardiac output monitoring. A quote has been requested via email, and negotiations have been held with Getinge Finland Oy. The estimated total value of the procurement, EUR 83,192 (excl. VAT), exceeds the national threshold. The estimated total value is calculated for a 48-month period for an indefinite contract. The procurement is in accordance with the Common Procurement Vocabulary (CPV) of the European Union, CPV code 33100000-1. The contracting entity may choose direct award on the following grounds: Act on Public Procurement and Concession Contracts (1397/2016) Section 40 Direct Award 2) for technical reasons or reasons relating to the protection of exclusive rights, only a specific supplier can carry out the procurement; an additional condition is that there are no reasonable alternative or substitute solutions and that the lack of competition is not due to an artificial restriction of the procurement conditions. The contracting entity may choose direct award on the aforementioned grounds because the assessment of the clinical need of the intensive care unit has examined the available hemodynamic monitoring methods and their measurement methods in relation to the clinical need described above. The assessment found that the uncalibrated pulse wave-based systems in use and available on the market do not provide measurement data for extravascular lung water (EVLWI) and global end-diastolic volume (GEDI), which are essential for the unit's operations in optimizing fluid therapy and circulation for critically ill intensive care patients. According to the unit's assessment, the PiCCO system is the only identified solution that simultaneously meets the requirements for continuous hemodynamic monitoring and measurement of lung water and preload based on transpulmonary thermodilution. For this reason, no alternative solution meeting the technical and functional requirements has been identified. The device procurement, Pulsiocare hemodynamic monitor, costing EUR 15,800 (excl. VAT), will be funded from the investment appropriations for 2026 (investment number 1120). The total value of the procurement, EUR 83,192 (excl. VAT), exceeds the national threshold and consists of the device's purchase price, device-specific consumables procured under an indefinite contract, and post-warranty calibration. Eloisa commits to ordering 7 boxes of PiCCO catheters and 4 boxes of ProAQT sensors annually. The total value of the procurement is calculated for a 48-month period for an indefinite contract.

Data provenance

This notice is sourced from Hilma Finland and was originally published on November 14, 2026. Last refreshed today. Original language: fi. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Etelä-Savon hyvinvointialue

Etelä-Savon hyvinvointialue has issued 323 procurement notices on BidsFactory, including 16 currently open and 245 awarded contracts. Activity concentrates in Health & Medical, Social Protection & Welfare, and General Supplies & Services. All notices are published for Finland. Notices are distributed via Hilma Finland and TED - Tenders Electronic Daily (EU). Most recent publication: November 17, 2026.

Etelä-Savon hyvinvointialue: buyer profile, tenders and awards

Frequently asked questions about this tender

What type of contract is this?

This is a Supplies contract in the General Supplies & Services sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Finland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit Hilma Finland to access the full notice, required documents, and submission instructions provided by the contracting authority.

Who is the contracting authority?

This notice was issued by Etelä-Savon hyvinvointialue in Finland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

Find tenders like this automatically

Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.

See plans

Key Details

Contract Type
Supplies
Eligibility
Firms / Consortiums
Language
fi

Source

hilma_fi
Hilma Finland
Public Procurement

Contracting Authority

Etelä-Savon hyvinvointialue
🇫🇮Finland